Choosing A Vision Supplement: Seven Checks

A recommendation goes out of date the moment a formula changes, and it asks you to trust whoever wrote it. A set of questions does not.

The seven below are chosen because each one can be answered from the back of a pack in under a minute, and because each one separates products that are otherwise indistinguishable from the front. None of them requires remembering a trial.

They are ordered by how much they tell you. The first three decide most purchases. The last four are the ones that matter when the first three are close.

At the end all seven are applied to OptiCore Pro, the product this website sells. It fails four of them, and those four are set out before the three it passes.

Three passes and four fails. The passes are only worth reading because the fails are printed above them.

Four out of seven is a poor score and it is the honest one. It is also a specific score rather than a general verdict: this label fails on disclosure inside the blend, on the two carotenoids, on the antioxidant amounts and on the seal wall.

What the three passes say is that the failures are not carelessness. A formula that names the plant part of five botanicals and prints a Daily Value against sixteen rows was written by somebody paying attention. It was simply written as a multivitamin with a hair and nail blend, and sold with an eye framing.

Check one. The blend is 179.5 mg across eleven botanicals with no individual amount. Split evenly that is about 16 mg each, and nothing in the list has human research at anything like that. The horsetail trials used 900 mg a day of dried extract; the plant sterol work runs in grams. The format itself is the failure, not the botanicals.

Check two. No lutein and no zeaxanthin anywhere on the label. The AREDS2 secondary analysis is the reason every serious eye formula carries them, and the screen-hours work is built on the same pair. This is the row a reader coming from any modern eye formula will notice first.

Check three. Vitamin C at about an eighth of the trial amount, vitamin E at about a twenty-fifth, zinc at about a twenty-second of the original AREDS figure. Every one of those rows is a sensible multivitamin amount and none of them is a trial amount, and the difference is the whole distance between the two kinds of product.

Check six. Three seals name no certifying organisation, and the fourth names a regulator that has approved nothing. The money-back seal prints neither a period nor a condition while the policy behind it has both. The testing and quality page audits all four at length.

Check four is a pass that needs explaining, because it looks like an absence. Copper is in the AREDS formula for one reason: 80 mg of zinc oxide over years depresses copper status, and the case literature is what that looks like when it goes far enough. At 3.62 mg there is nothing to offset, so leaving copper out is the correct decision. A label that copied the copper without the zinc would have been copying the wrong half.

Check five is a genuine credit. Naming Equisetum arvense as whole plant, Polygonum multiflorum as root and Phyllostachys nigra as leaf is more than a great deal of this category bothers with, and it is the difference between a botanical you can look up and one you cannot. The nettle literature is the standing example of why the plant part decides everything.

Check seven is a pass with a caveat rather than without one. 60 days is long enough to test a nutrient capsule, opened bottles are included, and the start date arrives in your inbox with a tracking number. The caveat is that it runs from shipping rather than delivery, so transit comes out of the window.

Three passes out of seven is not a recommendation and is not meant as one. What it is is the reason the four failures are worth taking seriously: they come from a label that is otherwise carefully written.

The scorecard is more useful on other labels than on this one, because most of this category cannot be scored past the first question.

A great many eye supplements are a single proprietary blend with a total and nothing else, which means checks two through five are unanswerable. That is itself the answer: a product that cannot be scored is a product whose amounts you are being asked to take on faith.

The fastest sequence at a shelf is one, two, three, in that order. Does everything carry an amount; are the carotenoids there; are the antioxidant amounts near their trials. Three questions, about forty seconds, and the answer to most purchases.

If a label survives all three, the last four are worth the extra minute. And if you are buying for screen hours specifically, check two is close to the whole decision, because the intervention meta-analysis points everything else at blink breaks, screen distance and a correct working-distance prescription rather than at a capsule.

• Whether a product works. No scorecard measures effect, and almost no supplement in this category has been trialled as a finished formula.
• Whether the amounts printed are the amounts in the capsule. That needs a certificate of analysis for the lot, and almost nobody publishes one.
• Whether a formula suits you specifically. Iron, soy, existing medication and an autoimmune diagnosis all change the answer and none of them is on this card.
• Whether a price is fair. The checks are about disclosure and amounts, and a well-disclosed formula can still be expensive.
• Whether your symptoms need a supplement at all. A change in vision, flashes, floaters or pain belong with an optometrist or an ophthalmologist rather than on a shelf.

The habit worth forming is to answer all seven before turning a box over to its marketing side, because the front of a pack is built to answer questions nobody asked.

For the product this website sells, the answers are four failures and three passes, printed above rather than buried. Anyone who reads that and still wants the capsule is buying what is actually in the bottle, which is the only kind of purchase worth selling.